Hyam Levitsky - Net Worth and Insider Trading

Hyam Levitsky Net Worth

The estimated net worth of Hyam Levitsky is at least $10 Million dollars as of 2024-04-29. Hyam Levitsky is the EVP, Research & CSO of Juno Therapeutics Inc and owns about 116,700 shares of Juno Therapeutics Inc (JUNO) stock worth over $10 Million. Details can be seen in Hyam Levitsky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hyam Levitsky has not made any transactions after 2016-06-17 and currently still holds the listed stock(s).

Transaction Summary of Hyam Levitsky

To

Hyam Levitsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hyam Levitsky owns 4 companies in total, including Replimune Group Inc (REPL) , Juno Therapeutics Inc (JUNO) , and Agenus Inc (AGEN) among others .

Click here to see the complete history of Hyam Levitsky’s form 4 insider trades.

Insider Ownership Summary of Hyam Levitsky

Ticker Comapny Transaction Date Type of Owner
REPL Replimune Group Inc 2018-07-19 director
JUNO Juno Therapeutics Inc 2017-02-07 EVP & Research & CSO
AGEN Agenus Inc 2006-09-13 director
IPSC Century Therapeutics Inc 2022-01-25 President of R&D

Hyam Levitsky Latest Holdings Summary

Hyam Levitsky currently owns a total of 1 stock. Hyam Levitsky owns 116,700 shares of Juno Therapeutics Inc (JUNO) as of June 17, 2016, with a value of $10 Million.

Latest Holdings of Hyam Levitsky

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JUNO Juno Therapeutics Inc 2016-06-17 116,700 86.96 10,148,232

Holding Weightings of Hyam Levitsky


Hyam Levitsky Form 4 Trading Tracker

According to the SEC Form 4 filings, Hyam Levitsky has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 12,418 shares on June 17, 2016, which brought Hyam Levitsky around $531,118.

Insider Trading History of Hyam Levitsky

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hyam Levitsky Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hyam Levitsky Ownership Network

Ownership Network List of Hyam Levitsky

No Data

Ownership Network Relation of Hyam Levitsky


Hyam Levitsky Owned Company Details

What does Replimune Group Inc do?

Who are the key executives at Replimune Group Inc?

Hyam Levitsky is the director of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Commercial Officer Christopher Sarchi , Chief Medical Officer Konstantinos Xynos , and Chief Financial Officer Emily Luisa Hill .

Replimune Group Inc (REPL) Insider Trades Summary

Over the past 18 months, Hyam Levitsky made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 66,624 shares made by Pamela Esposito , a net sale of 25,067 shares made by Tanya Lewis , and a net sale of 21,273 shares made by Sushil Patel .

In summary, during the past 3 months, insiders sold 0 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 174,192 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 174,192 shares.

Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Replimune Group Inc Insider Transactions

No Available Data

Hyam Levitsky Mailing Address

Above is the net worth, insider trading, and ownership report for Hyam Levitsky. You might contact Hyam Levitsky via mailing address: C/o Antigenics Inc., 162 Fifth Ave., Suite 900, New York Ny 10010.

Discussions on Hyam Levitsky

No discussions yet.